indicated a parallel increase in the corresponding mRNA levels, suggesting an effect of the inhibitor on the transcription of the gene.
Incorporation of exogenous farnesol into sterols and ubiquinone Q,,
Three-day-old TBY-2 cells were treated or not with 0.5 ,uM SQ for 24 h, then fed all-trans-[l-3H]farnesol (25 pCi) for 24 h. After freeze drying, cells were analysed for the radioactivity associated with individual free sterols [9] and ubiquinone Qln. Farnesol was found to be highly incorporated into all components of the sterol mixture, which consisted of stigmasterol (31 yo), sitosterol(l.5 yo), 24-methylcholesterol (31 yo) and cholesterol (1 %). Radioactivity was also recovered in the biosynthetic intermediates : 24-methylenecholesterol and isofucosterol, representing 3 1 and 9 n/ o of total sterols, respectively. T h e highest specific radioactivity, expressed in cpm/nmol, was associated with cholesterol.
Ubiquinone Qln was isolated from the same extract as sterols and was identified by positive fast atom bombardment (FAB)-MS. It was first purified by T L C , then by reversed-phase HPLC, after addition of cold carrier and detection at 275 nm. A radioactive peak was obtained, indicating that elongation of the prenyl side chain of ubiquinone Q,,, can arise from a C,, isoprenic unit derived from the cytosol, as in mammalian cells [lo] . After treatment of TBY-2 cells with 0.5pM SQ, no increase in the radioactivity of ubiquinone was found, suggesting that this pathway was already saturated under normal conditions. Experiments are currently under way to investigate the isoprenoid branches in which FPP molecules are redirected and at what level such metabolites might be implicated in the feedback control of the multi-branched isoprenoid pathway.
Introduction
Isoprenoids are derived from isopentenyl diphosphate (IPP) and fulfil vital functions in all known organisms. Plants form IPP for the synthesis of their plastidic isoprenoids via the non-mevalonate deoxyxylulose 5-phosphate/methylerythritol 4-phosphate (DOXP/MEP) pathway [l] . DOXP and MEP are the first two intermediates, formed by DOXP synthase (DXS) and DOXP reductoisomerase (DXR), respectively. T h e next three enzymic steps and genes of this isoprenoid pathway have been elucidated recently [2] . T h e DOXP/MEP pathway occurs in plants, bacteria and the malaria parasite, but not in humans.
Therefore, all its enzymes represent ideal potential targets, both for new herbicides and active substances against pathogenic micro-organisms. Conversely, every substance that blocks the DOXP/ M E P pathway in plants is a potential drug against pathogenic organisms containing this pathway. T h u s the antibiotic and herbicide fosmidomycin, with low toxicity for humans, inhibits not only the DXR enzyme of Arabidopsis [3, 4] but also blocks Plasmodium DXR and is able to heal mice infected with malaria [ S ] . In this article new clues to the mode of interference of the herbicide clomazone with the DOXP/MEP pathway are presented. T h e real mode of action of this herbicide blocking carotenoid accumulation is not yet known [6] . Moreover, several plant-derived in vitro and in vivo test systems, which are applicable in the search for new substances against Plasmodium falciparum and pathogenic bacteria, offer the advantage that plants often have much higher isoprenoid biosynthesis rates than bacterial systems and that work with plants does not require special safety precautions [7] . 
Greening of etiolated barley leaves

Conclusion
Plant test systems can be a first approach to studying inhibitors of the DOXP/MEP pathway of IPP biosynthesis. Inhibitors of this pathway, as exemplified by the DXR inhibitor fosmidomycin, have the potential to be active not only against plants, but also against bacteria and the malaria parasite P . falciparum [ S ] . Pathogenic apicomplexa such as Plasmodium can often be controlled by herbicidal substances with targets similar to those in plants but which differ or do not occur in humans [13, 14] . We have shown here the first steps towards the identification of a further 
